Using genetic engineering techniques, two strategies for brane fusion functions of HA on to two different molecules. changing the receptor-binding specificity of the influenza
approach using a different virus attachment/entry protein with well understood structure-to-function relationships. The haemagglutinin (HA) protein of influenza A virus fits this description since it has been exceptionally well characterised in terms of both three-dimensional structure and function. [17] [18] [19] The HA protein's role in influenza virus replication is to bind the virus to potential host cells by interacting with sialic acid residues on the cell surface, and then to mediate virus entry into the cell by fusing together the virus envelope and cell membrane in a low pH-dependent process. 20 It is initially synthesised as a single monomeric polypeptide, HA0, which is subsequently cleaved by a nonviral protease into two polypeptides, HA1 and HA2, linked together by a disulphide bond. This cleavage process is essential for its fusion activity. In terms of three-dimensional structure, HA consists of a membrane-distal globular head joined by a hinge to a stem region, the end of which is embedded in the virus envelope (or infected cell membrane). The globular head, formed from the HA1 polypeptide, carries the sialic acid receptor binding site. The stem, formed from HA2 and components of HA1, contains the region responsible for mediating fusion. After synthesis, HA monomers associate noncovalently to form homotrimers, and it is in this form that HA is found on the surface of the virus and infected cell.
Studies have shown that HA exhibits its fusion activity in the absence of any other virus-encoded proteins, 21 and that fusion activity (measured in an experimental system using influenza A virus particles and liposomes) is not dependent on a need to bind to sialic acid per se. 22 In addition, although each HA molecule has both attachment and fusion capability, there is evidence to suggest that these two functions are carried out by different HA molecules. 23 These observations indicate that it might be possible to alter the binding specificity of HA by replacing its sialic acid receptor site with an alternative receptor-binding domain, without compromising its fusion activity. Also, since no other influenza virus proteins are required for fusion, it should be possible to use HA, modified in this way, to create retrovirus pseudotypes (as has already been done with wild-type HA). 2, 24 Using genetic engineering techniques, we have begun to explore two strategies for changing the receptor-binding specificity of HA. In both, the aim is to replace the sialic acid binding pocket of HA with an alternative receptor-binding domain, formed from a single chain antibody Fv domain (scFv). The first strategy involves linking the scFv directly to HA to form a scFv-HA chimaeric protein. The second strategy is to construct a separate, artificial receptor-binding molecule incorporating the scFv, to take over the HA protein's receptor-binding function. The sialic acid binding site of the HA protein will be deleted by site-directed mutagenesis, leaving the HA protein with only its membrane fusion function intact. In this second scenario, both the artificial receptorbinding molecule and the HA protein will have to be present on the surface of a pseudotyped retrovirus particle to obtain antigen-specific entry into a cell.
To test the feasibility of the first strategy, a scFv specific for the hapten nitrophenyl acetic acid (NP) was linked directly to the globular head of HA, to create a scFv-HA chimaeric protein (Figure 1 . In addition to the scFv inter-VH-VL (Gly 4 Ser) 3 peptide linker, the scFv also possessed an upstream inter-HA1-VH (Gly 4 Ser) 4 linker and a downstream inter-VL-HA1 (Gly 4 Ser) 1 linker. Their purpose was to try and ensure that the scFv did not sterically interfere with the folding of the HA1 globular head. After assembly, the scFv-HA chimaeric gene was sub-cloned into the expression vector pH␤Apr-1-neo (to give plasmid p407) and transfected into CHO cells. A cell line (CHO407c) constitutively synthesising the chimaeric protein was identified by immunofluorescent staining using a pool of anti-HA protein monoclonal antibodies.
When screening the transfected CHO cells for chimaeric protein production, the cells were fixed in acetone to permeabilise the cell membranes before the staining procedure. Therefore the specific cellular location of the chimaeric protein (cell surface versus intracellular) could not be distinguished by this technique. In order to determine whether or not the chimaeric protein was being exported to the cell surface after synthesis as it should be and to obtain structural information about the protein, unfixed CHO407c cells were stained with anti-HA mAb HC19, HC31 HC67 or HC45, 26 using the staining procedure described in the legend to Figure 4 . The HA antigenic sites recognised by these mAbs are B1, B2, B2 and E respectively, as defined by Wiley et al 27 (the binding sites of HC31 and HC67 are not identical, being affected by different HA1 amino acid substitutions). The epitopes of all four mAbs are conformation-dependent, in that they are destroyed if the HA protein is denatured by Western blotting. HC31 and HC67 only react with native (neutral pH form) trimeric HA, whereas HC19 and HC45 react with both monomeric (low pH form) and native trimeric HA. All four of the mAbs reacted strongly with the CHO407c cells, indicating that the chimaeric protein was indeed present on the cell surface, and that the mAb epitopes were all intact. The positive result with HC31 and HC67 was particularly relevant as it indicates that the trimeric protein exists as a trimer on the cell surface.
To show that the chimaeric protein remained intact after synthesis (ie that it was not being inappropriately cleaved by a cellular proteolytic enzyme), its molecular weight was estimated by a combination of SDS-PAGE and Western blotting ( Figure 2 ). Computer analysis of the amino acid sequence of scFv-HA chimaeric protein predicted a molecular weight of 88.7 kDa in the absence of glycosylation. Wild-type HA protein is estimated to carry approximately 13 kDa of carbohydrate side chains. 17 As none of the HA protein glycosylation sites were destroyed during construction of the gene, the chimaeric protein should also have an extra 13 kDa of carbohydrate, giving a final predicted weight of approximately 102 kDa. The actual molecular weight of scFv-HA chimaeric protein produced by the CHO407c cells was estimated to be 103 kDa by Western blotting. This agreed well with the predicted weight, indicating that the scFv domain remained attached to the HA component of the chimaeric protein, ie that it has not been cleaved off at some posttranslation stage.
As described earlier, the HA protein of influenza A has to be cleaved into two fragments (HA1 and HA2) to acquire its membrane fusion function. During the natural infectious cycle, this cleavage event is mediated by a nonviral proteolytic enzyme which probably originates from certain cells or bacteria within the respiratory tract. 28, 29 CHO cells do not produce the necessary enzyme, but this deficit can be overcome by treating the cells briefly with a low concentration of trypsin, to cleave any HA0 on the cell surface into HA1 and HA2. For the scFv-HA chimaeric protein to have membrane fusion activity, it too must be cleaved in the same way as the wild-type HA protein. This was tested by treating CHO407c cells with trypsin, and then comparing lysates of these cells with untreated cells by Western blotting (Figure 2 ). The trypsin treatment cut the chimaeric protein into two bands, one of which was approximately the same size as the wild-type HA2 polypeptide. The molecular weight of the second band, which should correspond to HA1 linked to the scFv antibody fragment (scFv-HA1), was estimated as 73.5 kDa. This was approximately 10% greater than expected. However, a similar (13%) difference between the observed and expected weights of the HA1 fragment of wild-type HA protein has been reported previously by other researchers. 21 The trypsin digest pattern supported the results of the earlier mAb binding study, suggesting that the HA portion of the chimaeric protein folded correctly during synthesis despite the presence of the scFv domain in the centre of the HA1 sequence. Were the protein incorrectly folded, additional trypsin cleavage sites would probably be exposed and accessible to proteolytic attack, as is the case when wild-type HA is in its low pHinduced conformation. 30 The only cause for concern was the observation that the scFv-HA1 digestion product appeared as a pair of closely migrating bands. The reason for this is not known; perhaps they represent different glycoforms of this fragment of the chimaeric protein (it was not possible to ascertain conclusively from the blot whether the uncleaved scFv-HA chimaeric protein migrated as one or two bands). Alternatively, the trypsin may have trimmed off a short piece of HA1 after it made the initial cut at the main trypsin cleavage site: there are a number of potential sites (Lys-amino acid X) where this could occur at the C-terminal end of HA1. The trypsin digestion result also indicates that the majority of the chimaeric protein produced by the CHO407c cells is exported to the cell surface, as most of it was accessible to the trypsin. This is additional evidence suggesting that the chimaeric protein folds correctly, as previous studies on HA protein cellular expression have shown that HA is only exported to the cell surface if it has associated into trimers.
31,32
To confirm the antigen binding function of the chimaeric protein's scFv domain, a haemadsorption test was carried out on the CHO407c cells using human group O red blood cells (RBCs) that had been treated with neuraminidase (to remove surface sialic acid residues) and then coated with 3-nitro-4-hydroxy-5-iodophenylacetic acid (NIP; a derivative of NP) ( Figure 3 ). To investigate whether or not the chimaeric protein retained its endogenous sialic acid receptor-binding activity, the CHO407c cells were also tested against untreated (surface sialic acid-positive, NIP-negative) RBCs. The CHO407c cells adsorbed the NIP-RBCs, but not the untreated RBCs. This clearly demonstrated that the scFv domain of the chimaeric protein was functional and able to recognise its target antigen. It also showed that the HA component of the chimaeric protein had a greatly reduced affinity for sialic acid, possibly because the sialic acid binding pocket had been obscured by the attached scFv domain. The latter result was an advantageous side-effect of inserting the scFv between HA1 amino acids 139 and 145, which are close to the entrance of the binding pocket. Dual receptor-binding activity (via the scFv and the sialic acid binding site) would obviously compromise the specific cell targeting ability of a gene therapy vector carrying the chimaeric protein.
The fusigenic activity of scFv-HA chimaeric protein was investigated in a red blood cell fusion assay, using CHO407c cells. The CHO407c cells were first treated with trypsin to activate the chimaeric protein, and then used as targets for haemadsorption with neuraminidase treated NIP-conjugated RBCs that had been loaded with horseradish peroxidase. The CHO407c cells (with adsorbed RBCs) were then incubated briefly in low pH medium to induce the chimaeric protein to undergo the low pH conformational change associated with the fusion process. After a further period of incubation in normal pH medium (to give fusion between the CHO407c cells and the adsorbed RBCs a chance to occur), the CHO407c cells were stained with diaminobenzidine to detect the presence of any horseradish peroxidase transferred from the loaded RBCs. Disappointingly, no convincing evidence of chimaeric protein-mediated cell-to-cell fusion was seen.
The reasons underlying the failure to detect fusion activity in the chimaeric protein are unclear, but there are several possibilities. The first is that the presence of the scFv domain may prevent the HA portion of the molecule from undergoing the low pH-induced conformational change associated with the fusion process. To investigate 41 
Figure 2 Western blotting of CHO407c cell lysates. Monolayers of untransfected CHO cells (lane 1) or CHO407c cells (lanes 2 and 3), cultured in 24-well cluster trays, were detached from the plastic using PBS-EDTA and collected by centrifugation at 250 g for 5 min. Cells to be treated with trypsin (lane 3) were resuspended in 1 ml of serum-free cell

After electrophoresis, the gel was electroblotted on to cellulose nitrate paper using a Trans-blot apparatus (BioRad Laboratories, Hemel Hempsted, UK). The blot was blocked overnight at 37°C in PBS-0.05% Tween 20 containing 1% w/v BSA, 10% v/v foetal calf serum and 0.1% w/v sodium azide, then reblocked for a further 1 h in fresh blocking buffer. The blot was then stained with 1/500 rabbit anti-influenza virus X31 serum (provided by Dr A Hay, National Institute for Medical Research), followed by a mixture of 1/10 000 goat anti-rabbit peroxidase conjugate (Sigma A0545) and 1/10 000 Extra-avidin peroxidase (Sigma 2886). The blot was rinsed extensively in PBS-Tween in between each step; antiserum incubations were carried out for 1-h periods in blocking buffer without sodium azide. The blot was developed using ECL substrate (RPN 2109, Amersham Pharmacia Biotech, Little Chalfont, UK), following the manufacturer's instructions. The observed and (in brackets) the expected molecular weights of the scFv-HA chimaeric protein polypeptides are indicated.
this, trypsin-treated CHO407c cells were stained with two different anti-HA mAbs, HC31 and LC89, 26, 33 after the cells had been incubated briefly in either neutral pH medium or pH 5.0 buffer. The binding site of HC31 is located at the membrane-distal tip of HA, and its integrity depends upon the HA1 heads remaining in the native trimeric configuration. This binding site is destroyed in the early stages of the low-pH induced conformational change. The binding site of LC89 is located in HA2, and it is created when the region around HA2 amino acid 107 changes its structure from an alpha helix to a turn, during the later stages of the conformational change. 33 The 43 
After rolling at room temperature for 1 h, unbound NIP-Cap-OSu was removed by rinsing five times with PBS. Monolayers of CHO cells infected 24 h earlier with influenza A virus X31 at a multiplicity of approximately 10 (panels a and b) (X31 was supplied by Dr A Hay, National Institute for Medical Research) or monolayers of uninfected CHO407c cells (panels c and d), were tested for their ability to adsorb either untreated group Opositive human RBCs (panels a and c) or the neuraminidase treated, NIPconjugated RBCs (panels b and d) as follows. After rinsing of the monolayers to remove the culture medium, 1 ml of PBS containing 0.04% of the appropriate packed RBCs was added to each well and incubated at 4°C for 1 h. The monolayers were then rinsed four times with cold PBS to remove unbound RBCs, then examined under an inverted microscope. Neither untreated nor neuraminidase treated NIP-conjugated RBCs, bound to uninfected CHO cells (not shown). RBCs that had been neuraminidase treated but not conjugated to NIP did not bind to any of the three types of cells (not shown).
CHO407c cells which had been exposed to pH 5.0 before staining lost their reactivity to HC31 and gained reactivity to LC89, in proportions similar to those seen with influenza virus X-31-infected CHO cells (Figure 4 ). This result indicates that the chimaeric protein is able to make the gross structural changes associated with the fusion process. Even so, it is still possible that the presence of the scFv domain may be interfering with the fusion process in some way, perhaps by obstructing the access of the fusion peptide to the target membrane, or by blocking a downstream step in the fusion process, such as the aggregation of trimers which has been postulated to be necessary for fusion to proceed. 34 A second possible reason for the lack of fusion activity may be that the CHO407c cells do not produce enough of the chimaeric protein to initiate fusion. It has been shown previously 20 that a higher surface density of HA is needed to initiate fusion than to cause haemadsorption; perhaps the level of chimaeric protein produced by the CHO407c cells falls in between these two thresholds. Immunofluorescent staining data (Figure 4) suggests that the CHO407c cells have on average 1/5th of the HA pro- tein, in the form of chimaeric protein, as is found on the surface of X31-infected CHO cells. We are currently investigating whether wild-type HA protein would be able to mediate fusion if reduced to a similar level.
At the end of the 15-min trypsin incubation period the cells were rinsed once in normal cell culture medium containing 5% FCS, and then once in PBS. Each cell type was then split into two aliquots; one was incubated in suspension for 5 min at 37°C in neutral medium (serum-free IMDM cell culture medium) (H), the other was similarly incubated in PBS containing 10 mm HEPES + 10 mm MES, pH 5.0 (L). The cells were then rinsed once in ice-cold PBS containing 1% w/v BSA and 0.1% w/v sodium azide (FACS rinse buffer) and resuspended in the same buffer supplemented with 5% v/v heat-inactivated normal rabbit serum (FACS diluent
Although we have been unable to demonstrate fusion activity in the scFv-HA chimaeric protein described here, we have managed to identify a site on the HA protein where it is possible to insert a relatively large, discrete folding domain (in this case a scFv). It should be possible to use this same site for the insertion of smaller ligandbinding molecules. If the reason for our failure to detect fusion activity with the chimaeric protein is indeed steric interference from the scFv domain, the use of a smaller ligand binding domain or longer inter-scFv-to-HA1 linkers, might alleviate the problem.
The apparent lack of fusion activity of the scFv-HA chimaeric protein provided an opportunity to explore the second strategy for developing an enveloped gene therapy vector retargeting system based on HA. As described earlier, the intention here is to separate the attachment and membrane fusion functions on to two different molecules. The first, a membrane-bound artificial receptor-binding ligand, will incorporate the scFv. The second, the fusigenic molecule, will be HA protein engineered 35 to have a nonfunctional sialic acid binding site ( SA binding neg HA). This arrangement might circumvent any structural problems caused by linking the scFv directly to HA which, as described above, may have been responsible for the lack of demonstrable fusion activity in the scFv-HA chimaeric protein.
For this second strategy to be successful, it must be possible to complement the SA binding neg HA in trans using an adjacent receptor-binding (non-fusigenic) molecule. We used the scFv-HA chimaeric protein expressed by the CHO407c cells as a receptor-binding molecule to investigate whether or not such complementation was feasible. HA protein was introduced into the system by infecting the CHO407c cells with influenza A virus X31. The infected CHO407c cells, expressing the scFv-HA chimaeric protein and wild-type HA protein on their surface, were tested for their ability to adsorb and fuse to NIPRBCs ( Figure 5 ). Rather than destroying the receptorbinding function of the HA protein by site-directed mutagenesis, for the purpose of this experiment it was rendered operationally nonfunctional by treating the RBCs with neuraminidase. As described earlier, uninfected CHO407c cells were able to bind to, but not to fuse with neuraminidase treated NIP-RBCs. Ordinary CHO cells that had been infected with influenza A virus (and so expressed wild-type HA on their surface) were unable to bind to the NIP-RBCs because the neuraminidase treatment had removed the RBCs' surface sialic acid. However, the influenza A virus-infected CHO407c cells, which co-expressed the scFv-HA chimaeric protein and wildtype HA protein, were able to bind and fuse to the NIPRBCs. The extent of fusion was comparable to that observed between influenza virus-infected CHO cells (expressing only wild-type HA) and ordinary (sialic acidcoated) RBCs. As the NIP-RBCs did not have sialic acid on their surface, their attachment to the virus-infected CHO407c cells had to be mediated through the scFv-HA chimaeric protein. Conversely, because the chimaeric protein had no demonstrable fusion activity of its own, fusion between the NIP-RBCs and the virus-infected CHO407c cells must have been mediated by the wildtype HA protein. This observation supports the findings of Wharton et al 22 and Ellens et al, 23 namely, that the interaction between the HA sialic acid binding pocket and sialic acid per se is not a pre-requisite for HA fusigenic activity, and that the HA molecules mediating attachment are not necessarily those mediating fusion.
The above result shows that it is possible to separate the attachment and fusion functions of the influenza A virus HA protein on to different molecules, indicating that the development of a two-component attachment/ entry system for retargeting enveloped virus vectors, based on HA, is a viable proposition. The result would seem to suggest that the HA protein does not have to be bound directly to a receptor on the target cell membrane to bring about fusion, as long as the target membrane and the membrane carrying the HA protein are held in proximity by some other receptor-ligand interaction. However, it should be remembered that the HA protein 44 In brief, the cell monolayers were rinsed twice with PBS and then incubated in serum-free culture medium containing 2.5 g/ml trypsin for 15 min at 37°C. The monolayers were then used as targets for haemadsorption as described in Figure 3, is normally found on the surface of influenza virus particles and infected cells as a homotrimer. It is therefore possible that mixed trimers, containing both the scFv-HA chimaeric protein and wild-type HA protein, are formed on the surface of the influenza virus-infected CHO407c cells. Consequently, although it is true to say from the data presented here that at the level of the HA monomer, the HA protein does not have to be bound to a receptor in order to bring about membrane fusion, this cannot be extended to the trimer. It could be that only the mixed trimers (if they exist) are fusigenic. If so, it would mean that the artificial receptor-binding molecule component of a two-part attachment/entry system would have to be a chimaeric HA protein such as the one described here (to enable it to trimerise with SA binding neg HA). However, the work of Wharton et al, 22 which showed that HA could mediate fusion between influenza virus particles and liposomes that were devoid of sialic acid, suggests that the postulated requirement for mixed HA trimers is an overcomplicated interpretation of the results.
As HA-mediated fusion is independent of binding to sialic acid, it must be independent of any specific behavioural property of the underlying (cell surface) protein or lipid to which the sialic acid is linked. The sole function of the HA protein-to-sialic acid interaction during influenza virus infection is presumably to initiate transport of the virus particle into the endosome, and then to hold it in close proximity to the endosome membrane while the membrane fusion event takes place. There are likely to be many different cell surface antigens that could fulfil this role, a suggestion implicit in the ubiquitous nature of sialic acid, which is found attached to many different cell surface glycoproteins and glycolipids. It should therefore be possible to successfully target enveloped virus vectors carrying a HA-based attachment/entry system to cells via a wide range of different cell surface antigens. Having said this, it is likely that not all cell surface antigens will be equally permissive for infection initiation, because of the different ways they may behave when cross-linked by an adsorbed virus particle. Good target antigens will probably have to be identified empirically.
